ACHV Achieve Life Sciences, Inc.
$6.85▼ -1.15%
Healthcare
Other
After hours
$6.70▼ -2.20%
Oct 28, 4:46 PM ET
Volume 966.2K
Avg Volume (10D) 1.40M
Key Metrics & Fundamentals
Market Cap
$706.25M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.62 - 8.64
% vs 50 MA
-8.70%
% vs 200 MA
21.74%
RSI-14
46.3
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.85
Free Cash Flow
-$10.96M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$25.66M
COGS
–
Operating Exp
$18.39M
Operating Income
-$18.39M
EBIT
-$18.39M
Pretax Income
-$74.77M
Net Income
-$74.77M
EPS (Diluted)
-0.80
Price & Volume History
Loading chart…
Recent News

Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
GlobeNewswire · Oct 21, 2026 8:30 AM ET

Lisata adds biopharma finance veteran Jeffrey Farrow to board
Proactive · Oct 15, 2026 8:41 AM ET

Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
GlobeNewswire · Oct 14, 2026 4:05 PM ET

Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
GlobeNewswire · Oct 7, 2026 8:30 AM ET

Achieve Life Sciences Announces Granting of New Hire Inducement Awards
GlobeNewswire · Oct 6, 2026 4:02 PM ET
Achieve Life Sciences Names Benjamin Halladay CFO
MT Newswires · Oct 1, 2026 9:09 AM ET

Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
GlobeNewswire · Oct 1, 2026 8:30 AM ET
Stifel Initiates Achieve Life Sciences at Buy With $18 Price Target
MT Newswires · Sep 30, 2026 7:23 AM ET

Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
GlobeNewswire · Sep 28, 2026 8:30 AM ET

Achieve Life Sciences Announced Granting of New Hire Inducement Awards
GlobeNewswire · Sep 3, 2026 5:15 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ACHV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.